Back to Search
JEFFREY LIPTON, MD
MD
Clinical Pathology/Laboratory Medicine Physician
NPI: 1740395995IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical Pathology/Laboratory Medicine PhysicianPrimary
Pathology — Clinical Pathology/Laboratory Medicine
Code: 207ZP0105X
195035(NY)
CMS Specialties
PrimaryPATHOLOGY
Education
JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Class of 1987
Research & Publications (20)
Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis.
PMID 19327583·Hematol Oncol Clin North Am·2009
6-review
Diamond blackfan anemia: New paradigms for a "not so pure" inherited red cell aplasia.
PMID 16822459·Semin Hematol·2006
6-review
Mating worms and the cystic kidney: Caenorhabditis elegans as a model for renal disease.
PMID 15947985·Pediatr Nephrol·2005
6-review
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 28-2004. Newborn twins with thrombocytopenia, coagulation defects, and hepatosplenomegaly.
PMID 15356310·N Engl J Med·2004
5-case
Peripheral blood as a stem cell source for hematopoietic cell transplantation in children: is the effort in vein?
PMID 12603696·Pediatr Transplant·2003
6-review
Ecological risk assessment and natural resource damage assessment: synthesis of assessment procedures.
PMID 19545186·Integr Environ Assess Manag·2009
8-other
Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF.
PMID 19660547·Neurobiol Dis·2009
4-observational
Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain.
PMID 19555677·Brain Res·2009
7-preclinical
Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia.
PMID 19141860·Blood·2009
8-other
Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia.
PMID 19584153·Clin Cancer Res·2009
8-other
Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial.
PMID 19487385·J Clin Oncol·2009
3-trial
A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis.
PMID 19234505·Bone Marrow Transplant·2009
8-other
Macrolides in the treatment of bronchiolitis obliterans in allograft recipients.
PMID 19430505·Bone Marrow Transplant·2009
6-review
Examining the safety and efficacy of a chemotherapy dosing method in Allogeneic Stem Cell Transplant patients of extreme body size.
PMID 19276141·J Oncol Pharm Pract·2009
8-other
Peripheral blood eosinophilia has a favorable prognostic impact on transplant outcomes after allogeneic peripheral blood stem cell transplantation.
PMID 19285635·Biol Blood Marrow Transplant·2009
4-observational
Melatonin deficiency and disrupted circadian rhythms in pediatric survivors of craniopharyngioma.
PMID 19636054·Neurology·2009
8-other
Long-term behavioral consequences of prenatal MDMA exposure.
PMID 19162054·Physiol Behav·2009
4-observational
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value.
PMID 19641527·Leukemia·2009
8-other
16p11.2-related paroxysmal kinesigenic dyskinesia and dopa-responsive parkinsonism in a child.
PMID 19667324·Neurology·2009
5-case
Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen.
PMID 19438471·Br J Haematol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4802 10TH AVE
BROOKLYN, NY 11219 - Phone
- (718) 283-8773
Quick Facts
- NPI
- 1740395995
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile